A 54-year-old man, a chronic smoker, had an episode of haemoptysis. Investigations in his hometown suggested a mass in the lower lobe of the right lung. Tru-cut needle biopsy suggested adenocarcinoma. He came to Max Super Speciality Hospital, Saket, for further treatment. PET-CT revealed an FDG-avid 2.4 x 2.2 cm mass in the lower lobe of the right lung and an FDG-avid hilar (N1) lymph node with no FDG-avid lesion elsewhere in the body.
The MRI of the brain was normal. The patient underwent robotic right lower Lobectomy and systematic mediastinal lymph node dissection. The robotic approach is currently the most minimal invasive approach. Thoracic robotic surgery is a safe technique also for those complex cases, which in the past were considered a matter solely for open surgery.
Robotic Lobectomy has the greatest benefit in patients with marginal pulmonary function. The chest drain was removed on post-operative day 3, and he was discharged on post-operative day 7. The histopathology report suggested adenocarcinoma, stage IIB. He was referred for adjuvant Chemotherapy.
Robotic technology provides improved three-dimensional visualisation, increased freedom of instrument motion, and precise instrument movement with 3:1 motion scaling.
Treated by:
